PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
Tamara L. Lotan(Johns Hopkins University), Angelo M. De Marzo(Johns Hopkins University)
Cited by 350
Related Papers
MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells
|PLoS ONE|2010|134
The Dietary Charred Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-<i>b</i>]Pyridine Acts as Both a Tumor Initiator and Promoter in the Rat Ventral Prostate
|Cancer Research|2007|104
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
|Modern Pathology|2018|100
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
|Modern Pathology|2016|90
Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
|Prostate Cancer and Prostatic Diseases|2013|76